BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AstraZeneca PLC (AZN) Expands R&D in China to Boost Drug Discovery; Pharmaron LLC Will Add Hundreds of Scientists to Astra Team


10/15/2012 6:40:27 AM

AstraZeneca Plc (AZN), which has the worst-performing stock this year among Europe’s biggest drugmakers, will work with a research company in China to speed discovery of new medicines.

The partnership with Beijing-based Pharmaron will add “a few hundred” scientists to AstraZeneca’s 300-strong team in China, Martin Mackay, AstraZeneca’s president of global R&D, said in an interview in Shanghai. The move marks the London- based company’s biggest expansion in research in the world’s fastest-growing pharmaceuticals market.

Read at ChinaBio Today
Read at Bloomberg

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->